A Multi-cohort, Randomized Study in Healthy Subjects to Assess the Pharmacokinetics and Safety of Single and Multiple Ascending Doses of JNJ-61393215 (Suspension), and to Assess the Relative Bioavailability, and the Effect of Food on the Pharmacokinetics, of a New Solid Formulation (Capsules) of JNJ-61393215
Phase of Trial: Phase I
Latest Information Update: 30 Jan 2019
Price : $35 *
At a glance
- Drugs JNJ 61393215 (Primary)
- Indications Unspecified
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Janssen Research & Development
- 22 Jan 2019 Status changed from recruiting to completed.
- 06 Sep 2018 Status changed from not yet recruiting to recruiting.
- 05 Sep 2018 New trial record